Skip to main content
Predicting immune checkpoint therapy for breast cancer patients using LRRK2 mutations

Predicting immune checkpoint therapy for breast cancer patients using LRRK2 mutations

Unmet Need The treatment of various cancers has been revolutionized by the development of effective immunotherapies that are now established as powerful clinical tools. Unfortunately, it is also now well documented that only a minority…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us